ArticleCureus2025
Prioritizing Kidney Transplantation During COVID-19: A Single-Center Experience and Lessons for Future Surge Planning.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The COVID-19 pandemic disrupted elective surgical services, leading to the adoption of prioritization frameworks such as the Medically Necessary, Time-Sensitive (MeNTS) score. Cohort data from the initial pandemic year remains relevant when contextualized by later developments (vaccination rollout, targeted therapeutics, and recovery of transplant services). We evaluated case selection at the Cardiff Transplant Unit using MeNTS and early outcomes for patients considered for kidney transplantation during the first year of the pandemic. Methodology This single-center, retrospective, cohort study included adult patients considered for kidney transplantation between March 1, 2020, and March 1, 2021. MeNTS scores were calculated retrospectively for patients who received transplantation (n = 62) and those whose procedures were suspended (n = 45). Primary outcomes included early graft function and 90-day survival, one-year survival, and incidence/severity of COVID-19 infection. Results In total, 62 patients received transplantation, and 45 were suspended. The median cumulative MeNTS score was 58 (range = 52-64) in transplanted patients versus 61 (range = 57-65) in suspended patients (mean = 57.5 vs. 61.6; Mann-Whitney U = 401, Z = -6.269, p = 3.6 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.